Skip to content
Screener

Free cash flow at other companies

Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc.INDV
-$29M-141%
AVN
AVNSAVNS
-$16.6M-187%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$22.96M-14.7%
Bioventus logo
BioventusBVS
$18.91M-25.1%
Organon logo
OrganonOGN
$188M+337%
Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
$130.46K-84.0%

Other financials

Income statement

See full
Revenue$199.9M+6.3%
Gross profit$110.3M+1.8%
Operating income$3.7M-89.5%
Net income-$15.1M-226%
EPS (diluted)-$0.46-235%

Balance sheet

See full
Cash & equivalents$150.4M+8.8%
Total debt$5.0M-19.8%
Total equity$311.9M+34.3%
Total assets$2.1B+34.1%

Cash flow

See full
Operating cash flow$71.3M-1.5%
CapEx$496.0K+663%

Valuation

See full
Market cap$944.15M-1.3%
Enterprise value$798.74M-3.1%
P/E19.7×-6.7×
P/S1.2×-0.2×

Profitability

See full
Gross margin60%+3.3pp
Operating margin19.5%+1.1pp
Net margin5.9%+0.8pp
FCF margin40.6%+10.8pp

Returns & leverage

See full
Return on equity17.6%+1.4pp
Debt / equity0.0×
Current ratio-0.2×

Where this comes from

Calculated from Collegium Pharmaceutical, Inc.’s reported figures.

The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 7:34 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053851

FAQ

What is Collegium Pharmaceutical, Inc.'s free cash flow?
Collegium Pharmaceutical, Inc. (COLL) reported free cash flow of $70.83M in Q2 2026.
How has Collegium Pharmaceutical, Inc.'s free cash flow changed year-over-year?
Collegium Pharmaceutical, Inc.'s free cash flow decreased by 2.1% year-over-year, from $72.37M to $70.83M.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s free cash flow?
Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s free cash flow has grown at a 34.0% compound annual growth rate (CAGR), from $101.61M to $327.58M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.

Ask your AI about Collegium Pharmaceutical, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude